Investor mix
5 investors on record; lead investors include Saisei Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 80% |
| Other / undisclosed | 1 | 20% |
Developer of chimeric antigen receptor T-cell therapies for cancer
5 investors on record; lead investors include Saisei Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 80% |
| Other / undisclosed | 1 | 20% |